Skip to main content
. 2022 Sep 16;2022:3512582. doi: 10.1155/2022/3512582

Table 21.

Analysis of multiple drug resistance rate of CREs in 2019.

Drugs Drug resistance rate (%)
CREs Ampicillin-sulbactam 97.1
Imipenem 88.9
Ceftriaxone 84.9
Ertapenem 83.6
Ceftazidime 82.7
Nitrofurantoin 79.4
Ciprofloxacin 78.9
Aztreonam 77.3
Levofloxacin 76.8
Cefepime 75.8
Piperacillin-tazobactam 74.5
Cefoperazone-sulbactam 70.4
Gentamicin 53.5
Tobramycin 50.0
Cotrimoxazole 43.3
Amikacin 31.6
Tigecycline 0.0